Longbin Liu Chairman of Board Ph.D
In early 1980s, the rise of the global biotech revolution offered opportunities for overseas Chinese scientists to walk alongside their counterparts in the developed countries. During research and exploration processes, biologists have been keenly aware that it is of utmost significance and broad prospects to enhance the functions and activities of the known protein drugs by implementing protein engineering technology...>>Read More
Novaferon specially approved by SFDA for both phase 2 and 3 clinical trials
Novaferon was specially approved by SFDA for both phase 2 and 3 clinical trials for treatment of patient with advanced pancreatic cancer on March 28...
>> Read More
Novaferon was specially approved by SFDA for both phase 2 and 3 clinical trials for treatment of patient with advanced pancreatic cancer on March 28...
>> Read More
Clinical study of Novaferon for treatment of Active Hepatitis B Infection la
Details of the planned clinical trials of Novaferon, an innovative therapeutic protein patented in USA as a new molecular entity recently...
>> Read More
Details of the planned clinical trials of Novaferon, an innovative therapeutic protein patented in USA as a new molecular entity recently...
>> Read More
The Vice Mayor of Beijing Met The Executive Team Of Genova BioTech
On the morning of 29th January, 8 members of executive team includes the Chairman Longbin Liu, the president Donghua Pei and other vice presidents went to the B...
>> Read More
On the morning of 29th January, 8 members of executive team includes the Chairman Longbin Liu, the president Donghua Pei and other vice presidents went to the B...
>> Read More
